Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer

[1]  Yushui Ma,et al.  Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4 , 2021, Cell Death Discovery.

[2]  Yushui Ma,et al.  The power and the promise of circRNAs for cancer precision medicine with functional diagnostics and prognostic prediction. , 2021, Carcinogenesis.

[3]  Su Yao,et al.  Targeting Cholesterol Biosynthesis Promotes Anti-tumor Immunity by Inhibiting Long Noncoding RNA SNHG29 Mediated YAP Activation. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Lin Wang,et al.  A novel autophagy‐related lncRNA survival model for lung adenocarcinoma , 2021, Journal of cellular and molecular medicine.

[5]  L. Yao,et al.  CircRNA circ_0006677 Inhibits the Progression and Glycolysis in Non–Small-Cell Lung Cancer by Sponging miR-578 and Regulating SOCS2 Expression , 2021, Frontiers in Pharmacology.

[6]  Jiaying Wu,et al.  Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy. , 2021, Cancer letters.

[7]  R. Kulkarni,et al.  A Systematic Comparison of Protocols for Recovery of High-Quality RNA from Human Islets Extracted by Laser Capture Microdissection , 2021, Biomolecules.

[8]  Y. Ba,et al.  SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner , 2021, Translational oncology.

[9]  X. Shu,et al.  Incorporating Both Genetic and Tobacco Smoking Data to Identify High-Risk Smokers for Lung Cancer Screening. , 2021, Carcinogenesis.

[10]  J. Wenthe,et al.  Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes , 2021, Molecular therapy oncolytics.

[11]  Bingbing Ni,et al.  A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1/PD-L1 immunotherapy in advanced stage non-small-cell lung cancer. , 2021, American journal of translational research.

[12]  L. Shang,et al.  Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC , 2020, Molecular therapy. Nucleic acids.

[13]  Yanjie Zhao,et al.  Serial assessment of circulating T lymphocyte phenotype and receptor repertoire during treatment of non-muscle invasive bladder cancer with adoptive T cell immunotherapy. , 2020, American journal of cancer research.

[14]  Yushui Ma,et al.  Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs. , 2021, American journal of cancer research.

[15]  Chong Xu,et al.  EIF3m promotes the malignant phenotype of lung adenocarcinoma by the up-regulation of oncogene CAPRIN1. , 2021, American journal of cancer research.

[16]  P. Crooks,et al.  Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC , 2020, Cancer letters.

[17]  Shuzhen Chen,et al.  Silencing of lncRNA LINC00857 Enhances BIRC5-Dependent Radio-Sensitivity of Lung Adenocarcinoma Cells by Recruiting NF-κB1 , 2020, Molecular therapy. Nucleic acids.

[18]  F. Kassie,et al.  Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis. , 2020, Carcinogenesis.

[19]  C. Ottmann,et al.  Ultra-large chemical libraries for the discovery of high-affinity peptide binders , 2020, Nature Communications.

[20]  M. Mrug,et al.  Role of chemokines, innate and adaptive immunity. , 2020, Cellular signalling.

[21]  Jun Li,et al.  Downregulation of the Circadian Rhythm Regulator HLF Promotes Multiple-Organ Distant Metastases in Non-Small Cell Lung Cancer through PPAR/NF-κB Signaling. , 2020, Cancer letters.

[22]  Kaiyu Liu,et al.  Programmable Synthetic Protein Circuits for the Identification and Suppression of Hepatocellular Carcinoma , 2020, Molecular therapy oncolytics.

[23]  Daniel J. Atwood,et al.  The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in mice. , 2020, Cellular signalling.

[24]  B. Shapiro,et al.  Characterization of Cationic Bolaamphiphile Vesicles for siRNA Delivery into Tumors and Brain , 2020, Molecular therapy. Nucleic acids.

[25]  Lanlan Shen,et al.  Classify multicategory outcome in patients with lung adenocarcinoma using clinical, transcriptomic and clinico-transcriptomic data: machine learning versus multinomial models. , 2020, American journal of cancer research.

[26]  P. Liu,et al.  Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with Pan-Cancer 1000 gene panel. , 2019, Cancer letters.

[27]  B. Fu,et al.  LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells , 2019, Molecular therapy. Nucleic acids.

[28]  W. Travis,et al.  [New WHO classification of lung adenocarcinoma and preneoplasia]. , 2016, Annales de pathologie.

[29]  Chon-Kit Kenneth Chan,et al.  Analysis of RNA-Seq Data Using TopHat and Cufflinks. , 2016, Methods in molecular biology.

[30]  M. Noguchi,et al.  Stratifin accelerates progression of lung adenocarcinoma at an early stage , 2015, Molecular Cancer.

[31]  Marie-Agnès Dillies,et al.  SARTools: A DESeq2- and EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data , 2015, bioRxiv.

[32]  Jill P. Mesirov,et al.  GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..

[33]  L. Seymour,et al.  Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.